Shimadzu and Seegene Announce Partnership

August 15, 2008

Shimadzu Corporation (Columbia, Maryland) and Seegene, Inc. (Rockville, Maryland) have entered into a partnership in which Seegene's polymerase chain reaction-based Seeplex tests will be combined with Shimadzu's MultiNA high-speed electrophoresis system for multipathogen analysis and detection.

Shimadzu Corporation (Columbia, Maryland) and Seegene, Inc. (Rockville, Maryland) have entered into a partnership in which Seegene's polymerase chain reaction?based Seeplex tests will be combined with Shimadzu's MultiNA high-speed electrophoresis system for multipathogen analysis and detection. The microchip electrophoresis system is designed for DNA and RNA nucleic acid size confirmation and quantification. The multipathogen tests reportedly are capable of detecting multiple pathogens in a single tube and can be used in molecular diagnostics for human, animal, plant, and microorganism applications.